---
$id: https://graph.org.ai/products/commodity/51162617
$type: Product
source: UNSPSC
code: "51162617"
title: "Cloperastine"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cloperastine

**UNSPSC Code**: 51162617
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular formula C20H24ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 69M5L7BXEK, chemically known as piperidine, 1-(2-((p-chloro-alpha-phenylbenzyl)oxy)ethyl)- but more generally known as cloperastine, which bears US NIH Compound Identifier 2805. European Medicines Agency schedules Cloperastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06737MIG. The term CLOPERASTINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 14, No. 1, 2000, List 43). World Health Organization schedules cloperastine in its Anatomical Therapeutic Chemical (ATC) Classification. CLOPERASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cloperastine under HS 29333999 and SITC 51574. As of Q4 2014, CLOPERASTINE remains US FDA's Preferred Term for this commodity. Cloperastine bears US NLM identifiers UMLS ID C0055930 and NCI Concept Code C78106. SMILES: CLC1CCC(C(OCCN2CCCCC2)C2CCCCC2)CC1.

